In the third episode, Prof. Mike Recher shares his great experiences in the treatment with subcutaneous immunoglobulins (SCIGs). He gives practical advice regarding treatment, background information on antibody levels during treatment and a small outlook on treatment with HyQvia®, a SCIG preparation with an innovative mechanism of action.
Moderator: Dr. med. Marcus Kuehn, specialist in allergology and clinical immunology at the Loewenpraxis Lucerne (website).
Guest: Prof. Mike Recher, Head Physician at the University center for immunology at the University hospital Basel and Principal Investigator at the Department of Biomedicine at the University of Basel (website and website).
External guest: Myriam Osswald, Nursing Specialist at Careformance (website).
Brightcove Video
Resources and Links:
[1] Krivan G, Jolles S, Granados EL, Paolantonacci P, Ouaja R, Cissé OA, Bernatowska E. New insights in the use of immunoglobulins for the management of immune deficiency (PID) patients. Am J Clin Exp Immunol. 2017 Nov 1;6(5):76-83. PMID: 29181272; PMCID: PMC5698561.
[2] Devonshire AL, Makhija M. Approach to primary immunodeficiency. Allergy Asthma Proc. 2019 Nov 1;40(6):465-469. doi: 10.2500/aap.2019.40.4273. PMID: 31690396.
Cuvitru®prescribing information: www.swissmedicinfo.ch
Healthcare professionals may request a complete copy of the cited literature from the pharmaceutical company.
C-APROM/CH/CUVI/0102_11/2023